| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10286020.2015.1047772 |
| P698 | PubMed publication ID | 26235354 |
| P2093 | author name string | Qian Liu | |
| Hua Sun | |||
| Dan Zhang | |||
| Xiao-Dong Liu | |||
| Xiu-Qi Bao | |||
| Feng-Peng Wang | |||
| P2860 | cites work | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance | Q24645668 |
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Multiple molecular mechanisms for multidrug resistance transporters | Q28297705 | ||
| Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function | Q28475378 | ||
| P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models | Q28540914 | ||
| The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line | Q33177639 | ||
| Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer | Q34524629 | ||
| Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes | Q34705924 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Mechanism-based cancer therapy: resistance to therapy, therapy for resistance | Q38255064 | ||
| The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade | Q38305824 | ||
| H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein. | Q39678602 | ||
| 5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells | Q39766827 | ||
| Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein | Q40109392 | ||
| Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance | Q40253550 | ||
| Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. | Q40507932 | ||
| Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine | Q40513903 | ||
| The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells | Q43871136 | ||
| Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance | Q44687014 | ||
| P433 | issue | 6 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 638-648 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of Asian Natural Products Research | Q15751668 |
| P1476 | title | Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6. | |
| P478 | volume | 17 |
| Q91345543 | Application of alkaloids in reversing multidrug resistance in human cancers |
| Q37411868 | Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity. |
| Q37330473 | Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance |
| Q52860317 | Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity. |
| Q57747585 | Isochondodendrine and 2′-norcocsuline: additional alkaloids from Triclisia subcordata induce cytotoxicity and apoptosis in ovarian cancer cell lines |
| Q38725048 | Salvianolic acid B reverses multidrug resistance in HCT‑8/VCR human colorectal cancer cells by increasing ROS levels |
| Q58791987 | The Effects of Synthetically Modified Natural Compounds on ABC Transporters |
Search more.